5-S-Cysteinyldopamine
Showing 1 - 25 of >10,000
Liver Cirrhosis Trial in New Delhi (20% Albumin, 5% Albumin, Plasmalyte)
Not yet recruiting
- Liver Cirrhosis
- 20% Albumin
- +2 more
-
New Delhi, Delhi, IndiaInstitute of Liver & Biliary Sciences (ILBS)
Oct 6, 2023
L5-S1 Disc Fate in Thoracolumbar Arthrodesis Stopping at L5
Active, not recruiting
- Spinal Deformity
-
Paris, FranceGroupe Hospitalier Paris Saint-Joseph
Oct 4, 2022
Emotions, Separation Anxiety, Pain, Procedural Trial in Shanghai (S-ketamine 0.3, S-ketamine 0.5, S-ketamine 2)
Completed
- Emotions
- +2 more
- S-ketamine 0.3
- +4 more
-
Shanghai, ChinaEye and ENT Hospital of Fudan University
Apr 20, 2022
COVID-19 Trial (Bivalent BNT162b2 (original/Omicron BA.4/BA.5) 3 microgram dose, Bivalent BNT162b2 (original/Omicron BA.4/BA.5)
Not yet recruiting
- COVID-19
- Bivalent BNT162b2 (original/Omicron BA.4/BA.5) 3 microgram dose
- +3 more
- (no location specified)
Dec 22, 2022
Malaria Trial in Kumasi, Kisumu (RTS,S/AS01E (Full dose), RTS,S/AS01E (1/5th dose), Rabies vaccine)
Completed
- Malaria
- RTS,S/AS01E (Full dose)
- +2 more
-
Kumasi, Ghana
- +1 more
Jan 24, 2023
Dysentery, Shigellosis Trial in China (S. Flexneriza-S. Sonnei Bivalent Conjugate Vaccine, Placebo)
Recruiting
- Dysentery
- Shigellosis
- S. Flexneriza-S. Sonnei Bivalent Conjugate Vaccine
- Placebo
-
Hezhou, Guangxi, China
- +8 more
Jan 6, 2022
Colorectal Cancer, Urologic Cancer, Gynecologic Cancer Trial (acetated Ringers, albumin 5%, albumin 20%)
Not yet recruiting
- Colorectal Cancer
- +4 more
- acetated Ringers
- +2 more
- (no location specified)
Feb 9, 2023
Gastric Cancer Trial in Seoul (Docetaxel (XRP6976), Oxaliplatin (SR96669), S-1 (1-(2-tetrahydrofuryl)-5-fluorouracil +
Active, not recruiting
- Gastric Cancer
- Docetaxel (XRP6976)
- +2 more
-
Seoul, Korea, Republic ofAdministrative Office
May 3, 2022
Pain, Acute Trial in Salt Lake City (S-Ibuprofen, Vehicle)
Completed
- Pain, Acute
-
Salt Lake City, UtahJBR Clinical Research
Dec 29, 2021
Acute Myeloid Leukemia (AML) Trial in Leipzig (VEN+AZA-5)
Not yet recruiting
- Acute Myeloid Leukemia (AML)
-
Leipzig, GermanyUniversitätsklinikum Leipzig, Klinik und Poliklinik für Hämatolo
Apr 25, 2023
Head and Neck Squamous Cell Carcinoma Trial in United States (TAK-676, Carboplatin, 5-FU)
Completed
- Head and Neck Squamous Cell Carcinoma
- TAK-676
- +8 more
-
Shreveport, Louisiana
- +3 more
Oct 3, 2023
Tobacco Use Cessation Trial in Toronto (Nicotine patch)
Completed
- Tobacco Use Cessation
- Nicotine patch
-
Toronto, Ontario, CanadaCentre for Addiction and Mental Health
Jan 16, 2023
SARS-CoV-2 Infection Trial in Bangkok (Full dose of Ad26.COV2. 5x10^10vp, Half dose of Ad26.COV2. 2.5x10^10vp)
Recruiting
- SARS-CoV-2 Infection
- Full dose of Ad26.COV2. 5x10^10vp
- Half dose of Ad26.COV2. 2.5x10^10vp
-
Bangkok, ThailandVaccine Trial Centre, Faculty of Tropical Medicine, Mahidol Univ
Sep 11, 2022
Allergic Rhinitis Trial in Toronto (AllerPops)
Completed
- Allergic Rhinitis
- AllerPops
-
Toronto, Ontario, CanadaDicentra
Jul 20, 2023
Short- and Medium-term Evaluation of Mastoid Filling Using
Not yet recruiting
- Cholesteatoma
- verre bioactif 45S5 GlassBONE
- verre bioactif S53P4 Bonalive
-
Lyon, Pierre-Bénite, FranceHôpital Lyon Sud
Jun 16, 2023
Depression, Anxiety Trial in Regina (Wellbeing Course for Students (Fast Track), Wellbeing Course for Students (5 weeks),
Recruiting
- Depression
- Anxiety
- Wellbeing Course for Students (Fast Track)
- +2 more
-
Regina, Saskatchewan, CanadaOnline Therapy Unit, University of Regina
Sep 20, 2022
Inflammatory Disease, Disease Crohn, Bowel Disease Trial in Amsterdam (Infliximab subcutaneous, Immunosuppressive Agents)
Recruiting
- Inflammatory Disease
- +2 more
- Infliximab subcutaneous
- Immunosuppressive Agents
-
Amsterdam, North Holland, NetherlandsAmsterdam UMC AMC
Sep 27, 2023
Dysentery, Dysentery, Bacillary Trial in Quanzhou (S.Flexneriza-S.Sonnei Bivalent Conjugate Vaccine, Haemophilus b Conjugate
Completed
- Dysentery
- Dysentery, Bacillary
- S.Flexneriza-S.Sonnei Bivalent Conjugate Vaccine
- Haemophilus b Conjugate Vaccine
-
Quanzhou, Guangxi, ChinaQuanzhou Center for Disease Control and Prevention
Dec 28, 2021
COVID-19 Trial in Newport Beach (hAd5-S-Fusion+N-ETSD, Placebo (0.9% (w/v) saline))
Completed
- COVID-19
- hAd5-S-Fusion+N-ETSD
- Placebo (0.9% (w/v) saline)
-
Newport Beach, CaliforniaHoag Memorial Hospital Presbyterian
Sep 1, 2023
GSK's Phase IIb Malaria Vaccine Trial Entitled "Efficacy, Safety
Active, not recruiting
- Malaria
-
Kumasi, Ghana
- +1 more
Jun 23, 2022
Diabetes Type 2 With Proteinuria, Diabetes, Type 2, Diabetes Trial (drug, device, diagnostic test, behavioral)
Not yet recruiting
- Diabetes Mellitus Type 2 With Proteinuria
- +12 more
- Empagliflozin 10 MG
- +6 more
- (no location specified)
Oct 17, 2023
Erectile Dysfunction Following Radiation Therapy, Phosphodiesterase Inhibitor Adverse Reaction, Platelet- Rich Plasma (PRP)
Active, not recruiting
- Erectile Dysfunction Following Radiation Therapy
- +2 more
- P shot arm ( Autologous Platelet Rich Plasma)
- PDE5i arm
-
Mansoura, Outside U.S./Canada, EgyptMansoura urology and nephrology center
Mar 15, 2023
Detect CI (Cognitive Impairment) Study
Recruiting
- Cognitive Impairment (CI)
-
Toronto, Ontario, Canada
- +1 more
Sep 15, 2023
Knee Osteoarthritis Trial in Winnipeg, London (Neutral Mechanical Alignment, Anatomical Alignment)
Active, not recruiting
- Knee Osteoarthritis
- Neutral Mechanical Alignment
- Anatomical Alignment
-
Winnipeg, Manitoba, Canada
- +1 more
Sep 26, 2022
Pain Phenotyping in Knee OA: a Pilot Trial
Recruiting
- Observational Study; Association of Patient Pain Characteristics and Total Knee Arthroplasty Response
- n/a, observational
-
Hamilton, Ontario, Canada
- +1 more
Sep 27, 2023